Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease

被引:28
|
作者
Tremblay, Cyntia [1 ,2 ]
Francois, Arnaud [1 ,2 ]
Delay, Charlotte [3 ,4 ]
Freland, Laure [1 ,2 ]
Vandal, Milene [1 ,2 ]
Bennett, David A. [5 ]
Calon, Frederic [1 ,2 ]
机构
[1] Univ Laval, Fac Pharm, Quebec City, PQ, Canada
[2] Ctr Hosp Univ Quebec, Res Ctr, Neurosci Axis, 2705,Laurier Blvd,Room T2-2-67, Quebec City, PQ G1V 4G2, Canada
[3] Univ Lille, INSERM U1167, Res Grp, Facteurs risque & Determinants mol Malad, Lille, France
[4] Univ Lille, Med Ctr, Inst Pasteur Lille, Lille, France
[5] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL USA
基金
加拿大创新基金会; 加拿大健康研究院;
关键词
Alzheimer disease; Amyloid-beta; Mild cognitive impairment; Parietal cortex; Postmortem; Synaptic proteins; Tau; AMYLOID-BETA-PROTEIN; VESICULAR ACETYLCHOLINE TRANSPORTER; CHOLINE-ACETYLTRANSFERASE ACTIVITY; A-BETA; NEUROFIBRILLARY TANGLES; APOLIPOPROTEIN-E; EPISODIC MEMORY; SYNAPTIC PROTEINS; FRONTAL-CORTEX; CLINICAL-DIAGNOSIS;
D O I
10.1093/jnen/nlw109
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The associations between cognitive function and neuropathological markers in patients with mild cognitive impairment (MCI) and Alzheimer disease (AD) remain only partly defined. We investigated relationships between antemortem global cognitive scores and bamyloid (Ab), tau, TDP-43, synaptic proteins and other key AD neuropathological markers assessed by biochemical approaches in postmortem anterior parietal cortex samples from 36 subjects (12 MCI, 12 AD and 12 not cognitively impaired) from the Religious Orders Study. Overall, the strongest negative correlation coefficients associated with global cognitive scores were obtained for insoluble phosphorylated tau (r(2) = -0.484), insoluble A beta 42 (r-(2) = -0.389) and neurofibrillary tangle counts (r 2 = -0.494) (all p < 0.001). Robust inverse associations with cognition scores were also established for TDP-43-positive cytoplasmic inclusions (r(2) = -0.476), total insoluble tau (r 2 = -0.385) and Ab plaque counts (r(2) = -0.426). Sarkosyl (SK)- or formic acid (FA)- extracted tau showed similar interrelations. On the other hand, synaptophysin (r(2) = +0.335), pS403/404 TDP-43 (r(2) = +0.265) and septin-3 (r(2) = +0.257) proteins positively correlated with cognitive scores. This study suggests that tau and Ab42 in their insoluble aggregated forms, synaptic proteins and TDP-43 are the markers in the parietal cortex that are most strongly associated with cognitive function. This further substanti-ates the relevance of investigating these markers to understand the pathogenesis of AD and develop therapeutic tools.
引用
收藏
页码:70 / 88
页数:19
相关论文
共 50 条
  • [21] Neuropathological Findings in Parkinson's Disease With Mild Cognitive Impairment
    Knox, Molly G.
    Adler, Charles H.
    Shill, Holly A.
    Driver-Dunckley, Erika
    Mehta, Shyamal A.
    Belden, Christine
    Zamrini, Edward
    Serrano, Geidy
    Sabbagh, Marwan N.
    Caviness, John N.
    Sue, Lucia, I
    Davis, Kathryn J.
    Dugger, Brittany N.
    Beach, Thomas G.
    MOVEMENT DISORDERS, 2020, 35 (05) : 845 - 850
  • [22] Association of Plasma Transferrin With Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer's Disease
    Guan, Jingjing
    Wang, Peng
    Lu, Liping
    Zhao, Guanan
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 12
  • [23] Neuropathological findings in Parkinson's disease with mild cognitive impairment
    Knox, Molly
    Adler, Charles
    Shill, Holly
    Driver-Dunckley, Erika
    Mehta, Shyamal
    Belden, Christine
    Zamrini, Edward
    Serrano, Geidy
    Sabbagh, Marwan
    Caviness, John
    Sue, Lucia
    Davis, Kathryn
    Dugger, Brittany
    Beach, Thomas
    NEUROLOGY, 2019, 92 (15)
  • [24] Markers for the Risk of Progression from Mild Cognitive Impairment to Alzheimer's Disease
    Buratti, Laura
    Balestrini, Simona
    Altamura, Claudia
    Viticchi, Giovanna
    Falsetti, Lorenzo
    Luzzi, Simona
    Provinciali, Leandro
    Vernieri, Fabrizio
    Silvestrini, Mauro
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 45 (03) : 883 - 890
  • [25] Early markers of Alzheimer's disease in patients with minimal to mild cognitive impairment
    Devanand, DP
    Pelton, GH
    Tabert, MH
    Zamora, D
    Stern, Y
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 150S - 150S
  • [26] Voice Markers of Lexical Access in Mild Cognitive Impairment and Alzheimer's Disease
    Meilan, Juan J. G.
    Martinez-Sanchez, Francisco
    Carro, Juan
    Carcavilla, Nuria
    Ivanova, Olga
    CURRENT ALZHEIMER RESEARCH, 2018, 15 (02) : 111 - 119
  • [27] Cognitive training for persons with mild cognitive impairment
    Belleville, Sylvie
    INTERNATIONAL PSYCHOGERIATRICS, 2008, 20 (01) : 57 - 66
  • [28] CAREGIVER CONVERSATIONS WITH PERSONS WITH MILD COGNITIVE IMPAIRMENT, ALZHEIMER'S DISEASE, AND PARKINSON'S DISEASE
    Savundranayagam, Marie
    Schumann, Annette
    Orange, Joseph
    Pritchard, Sharon
    Pichora-Fuller, M. Kathleen
    Wittich, Walter
    Mick, Paul
    Campos, Jennifer
    INNOVATION IN AGING, 2024, 8 : 1035 - 1035
  • [29] Working memory and control of attention in persons with Alzheimer's disease and mild cognitive impairment
    Belleville, Sylvie
    Chertkow, Howard
    Gauthier, Serge
    NEUROPSYCHOLOGY, 2007, 21 (04) : 458 - 469
  • [30] Mild cognitive impairment - Risk of Alzheimer disease and rate of cognitive decline
    Boyle, P. A.
    Wilson, R. S.
    Aggarwal, N. T.
    Tang, Y.
    Bennett, D. A.
    NEUROLOGY, 2006, 67 (03) : 441 - 445